Harrow (HROW) Shares Outstanding (Diluted Average) (2016 - 2026)

Harrow (HROW) recorded quarterly Shares Outstanding (Diluted Average) of $37.2 million in Q1 2026, up 1.28% quarter-over-quarter from $36.8 million in Q4 2025, and up 3.92% on a YoY basis from $35.8 million in Q1 2025.

Harrow (HROW) Shares Outstanding (Diluted Average) (2016 - 2026) Analysis & Trends

Harrow's Shares Outstanding (Diluted Average) history runs 11 years deep, the most recent figure standing at $37.2 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 3.92% year-over-year to $37.2 million; the TTM figure through Mar 2026 stood at $37.2 million (up 3.92% YoY), while the FY2025 annual figure was $36.8 million, up 3.11% from the prior year.
  • Shares Outstanding (Diluted Average) was $37.2 million for Q1 2026 at Harrow, up from $36.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $37.2 million in Q1 2026 to a low of $27.2 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $33.1 million across 5 years, with a median of $35.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) dropped 0.92% in 2022, then rose 25.25% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $27.5 million in 2022, then increased by 18.78% to $32.6 million in 2023, then advanced by 9.3% to $35.7 million in 2024, then grew by 3.11% to $36.8 million in 2025, then rose by 1.28% to $37.2 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $37.2 million (Q1 2026), $36.8 million (Q4 2025), and $36.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn 37.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.23 Mn
Dec 31, 2025 36.76 Mn
Sep 30, 2025 36.59 Mn
Jun 30, 2025 36.30 Mn
Mar 31, 2025 35.83 Mn
Dec 31, 2024 35.65 Mn
Sep 30, 2024 35.60 Mn
Jun 30, 2024 35.54 Mn
Mar 31, 2024 35.47 Mn
Dec 31, 2023 32.62 Mn
Sep 30, 2023 34.26 Mn
Jun 30, 2023 30.46 Mn
Mar 31, 2023 30.29 Mn
Dec 31, 2022 27.46 Mn
Sep 30, 2022 27.35 Mn
Jun 30, 2022 27.30 Mn
Mar 31, 2022 27.23 Mn
Sep 30, 2021 26.63 Mn
Mar 31, 2021 27.48 Mn
Dec 31, 2020 25.90 Mn